Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
04/1991
04/24/1991CA2070416A1 Polypeptide inhibitors of gamma interferon
04/23/1991US5010057 Renin-inhibiting peptides having an aminomethyl side chain
04/23/1991CA1283500C Thiopeptolide substrates for vertebrate collagenase
04/23/1991CA1283499C Peptides
04/18/1991WO1991005058A1 Cell-free synthesis and isolation of novel genes and polypeptides
04/18/1991WO1991004743A1 Stabilized aqueous formulations of small peptides
04/18/1991DE3934366A1 Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum Vaccine to protect against hiv virus infections, methods for their production and their use as diagnostic and immunotherapeutic
04/17/1991EP0422938A1 Fibrinogen receptor antagonists
04/17/1991EP0422937A1 Fibrinogen receptor antagonists
04/17/1991CN1050721A Radiolabeled anticoagulant peptides
04/17/1991CN1050720A Anticoagulant peptides
04/16/1991US5007925 Prosthetic devices coated with polypeptides with type IV collagen activity
04/16/1991CA1283043C T-cell lymphotrophic virus protein and assay
04/14/1991WO1991005839A1 Dye transfer inhibition
04/14/1991WO1991005797A1 Methods and compositions for healing bone
04/14/1991WO1991005563A1 Therapeutic decapeptides
04/14/1991CA2067505A1 Methods and compositions for healing bone
04/14/1991CA2044137A1 Therapeutic decapeptides
04/14/1991CA2027315A1 Fibrinogen receptor antagonists
04/14/1991CA2027314A1 Fibrinogen receptor antagonists
04/13/1991CA2027455A1 Hiv related peptides
04/10/1991EP0421935A2 Insect neuropeptides
04/10/1991EP0421848A1 Process to stabilise peptides and process to synthetise peptides
04/10/1991EP0421682A1 Novel peptides, intermediates therefor, process for preparing the same, and antiallergic agents, vasodilators and immunoregulators
04/10/1991EP0421367A1 Anticoagulant peptides
04/10/1991EP0421366A1 Radiolabeled anticoagulant peptides
04/10/1991EP0420914A1 Cosmetic and skin treatment compositions.
04/10/1991CN1050545A Inhibitor of retroinfection viral protease
04/04/1991WO1991004272A1 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
04/04/1991WO1991004247A1 Chimeric amino acids and peptides containing these analogues
04/04/1991WO1991004055A1 Treatment of autoimmune disease
04/04/1991WO1991004051A1 Peptides including ctl epitopes of hiv proteins and use thereof
04/04/1991CA2026377A1 Radiolabeled anticoagulant peptides
04/03/1991EP0420649A2 Stabilized aqueous formulations of small peptides
04/03/1991EP0420562A1 Deacetoxycephalosporin C hydroxylase
04/03/1991CA2026618A1 Insect neuropeptides
04/02/1991CA1282550C2 Methods and compositions for preparation of h-arg-x-z-y-tyr-r
03/1991
03/30/1991WO1991005258A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region
03/30/1991CA2066674A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region
03/29/1991CA2026382A1 Inhibitors of retroviral proteases
03/29/1991CA2026149A1 Stabilized aqueous formulations of small peptides
03/27/1991EP0418590A1 Antibodies, production thereof and use
03/27/1991EP0418365A1 Controlled-action anesthetic compounds and pharmaceutical compositions containing same
03/27/1991EP0418233A1 Cysteine proteinase inhibitor
03/27/1991CN1050198A Peptidase and isomerase inhibitors
03/26/1991US5003011 Luteinizing hormone releasing hormone
03/26/1991US5002933 Hexapeptide and medicinal preparation produced from it to treat erosive and ulcerative lesions of gastrointestinal tract
03/24/1991CA2025941A1 Cns-active hexapeptides with an antiamnesic effect
03/23/1991WO1991004269A1 Medicament comprising antamanide
03/23/1991CA2066721A1 Medicament comprising antamanide
03/21/1991WO1991004045A1 Prophylaxis and therapy of acquired immunodeficiency syndrome
03/21/1991WO1991003556A1 Recombinant product
03/21/1991CA2065402A1 Prophylaxis and therapy of acquired immunodeficiency syndrome
03/20/1991EP0417819A1 Psycho-pharmacological peptides
03/20/1991EP0417721A2 Novel peptidase and isomerase inhibitors
03/20/1991EP0417563A2 TNF-binding proteins
03/20/1991EP0417454A2 Reduced size LHRH analogs
03/20/1991EP0417217A1 Peptides with sulphate ester groups
03/20/1991EP0417196A1 Immunogenic human interleukin-3 peptide and monoclonal antibodies thereto
03/20/1991EP0417165A1 Polypeptide compounds having growth hormone releasing activity.
03/20/1991CA2025634A1 Peptides including ctl epitopes of hiv proteins and use thereof
03/19/1991US5001230 T cell activation markers
03/19/1991US5001049 Method for determination of HIV specific antibodies
03/19/1991US5000952 Polypeptide pertussis toxin vaccine
03/13/1991EP0416652A2 Interferon-gamma receptor fragment and its production
03/13/1991EP0415981A1 Retroviral protease inhibitors
03/13/1991EP0415930A1 T cell activation markers
03/13/1991EP0403600A4 Deprotection of protected peptides
03/13/1991EP0394326A4 Conformationally stabilized cell adhesion peptides
03/12/1991CA2024661A1 Peptidase and isomerase inhibitors
03/09/1991WO1991003489A1 Structural alterations of the egf receptor gene in human gliomas
03/07/1991WO1991002751A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs
03/07/1991WO1991002749A1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP) AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF
03/07/1991WO1991002748A1 Rubella e1 peptides
03/07/1991WO1991002746A1 Therapeutic peptides
03/07/1991WO1991002745A1 Therapeutic peptides
03/07/1991CA2065017A1 Peptides from gtpase-activating protein (gap) and diagnostic and therapeutic use thereof
03/07/1991CA2064896A1 Therapeutic peptides
03/07/1991CA2039175A1 Therapeutic peptides
03/06/1991EP0415219A1 ANF-Antagonist
03/05/1991US4997648 Bactericide, antiinflammatory, immunosuppressive
03/02/1991CA2024053A1 Anf-antagonist
03/01/1991WO1991003488A1 Methods and compositions for healing ulcers
03/01/1991CA2065416A1 Methods and compositions for healing ulcers
02/1991
02/27/1991EP0414632A2 Cyclosporin derivatives
02/27/1991EP0413967A1 Novel antibiotic
02/27/1991EP0413766A1 Synthetic peptides for arterial imaging
02/27/1991EP0413762A1 Peptide analogs and their use as haptens to elicit catalytic antibodies
02/27/1991EP0413709A1 Fatty amino acids, and homo- and hetero-oligomers and conjugates thereof
02/27/1991CN1049505A Peptides having bradykinin-antagonistic action
02/26/1991WO1991002799A1 Fusion proteins
02/21/1991WO1991002005A1 Natural human anti-gamma interferon antibodies detected and purified by synthetic peptides
02/21/1991WO1991001754A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium
02/20/1991EP0413277A1 Peptide antagonists of bradykinin
02/20/1991EP0413209A1 LHRH analogs
02/20/1991CN1049353A Cyclic neurokinin a antagonists
02/19/1991WO1991002750A1 Novel inhibitors of thrombin
02/19/1991US4994554 Probursin
02/19/1991US4994553 Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
02/19/1991US4994270 Animal growth regulators
1 ... 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 ... 423